Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer

Schmidt, KL JuliëtteSevereijns, Noortje RDautzenberg, Noël MMHoogerbrugge, Peter MLindemans, Caroline ANierkens, StefanSmits, Gabyvan Binnendijk, Rob SFiocco, MartaBont, Louis JTissing, Wim JE2024-07-012024-07-012024-06-2010.1016/j.ejcped.2024.100172http://hdl.handle.net/10029/627693enLong-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancerArticleEJC Paediatric Oncol 2024; 4:100172